Translating Neonatal Microbiome Science into Commercial Innovation: Metabolism of Human Milk Oligosaccharides As a Basis for Probiotic Efficacy in Breast-fed Infants
Overview
Affiliations
For over a century, physicians have witnessed a common enrichment of bifidobacteria in the feces of breast-fed infants that was readily associated with infant health status. Recent advances in bacterial genomics, metagenomics, and glycomics have helped explain the nature of this unique enrichment and enabled the tailored use of probiotic supplementation to restore missing bifidobacterial functions in at-risk infants. This review documents a 20-year span of discoveries that set the stage for the current use of human milk oligosaccharide-consuming bifidobacteria to beneficially colonize, modulate, and protect the intestines of at-risk, human milk-fed, neonates. This review also presents a model for probiotic applications wherein bifidobacterial , in the form of colonization and HMO-related catabolic activity , represent measurable metabolic outcomes by which probiotic efficacy can be scored toward improving infant health.
The neonatal gut microbiome in health and disease.
Preidis G Gut Microbes. 2025; 17(1):2457499.
PMID: 39868670 PMC: 11776465. DOI: 10.1080/19490976.2025.2457499.
Human milk oligosaccharides: bridging the gap in intestinal microbiota between mothers and infants.
Sun W, Tao L, Qian C, Xue P, Du S, Tao Y Front Cell Infect Microbiol. 2025; 14():1386421.
PMID: 39835278 PMC: 11743518. DOI: 10.3389/fcimb.2024.1386421.
Wang Y, Huang Y, Rogers M, Leskinen H, Soppela P, Tuomivaara A Biology (Basel). 2024; 13(11).
PMID: 39596810 PMC: 11592061. DOI: 10.3390/biology13110855.
The human gut metacommunity as a conceptual aid in the development of precision medicine.
Tannock G Front Microbiol. 2024; 15:1469543.
PMID: 39464395 PMC: 11503762. DOI: 10.3389/fmicb.2024.1469543.
Ma Z, Zuo T, Frey N, Rangrez A Signal Transduct Target Ther. 2024; 9(1):237.
PMID: 39307902 PMC: 11418828. DOI: 10.1038/s41392-024-01946-6.